These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24965460)

  • 21. Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes.
    Barat C; Gilbert C; Imbeault M; Tremblay MJ
    Retrovirology; 2008 Mar; 5():30. PubMed ID: 18373845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 2-4-Amino Acid Deletion in the V5 Region of HIV-1 Env gp120 Confers Viral Resistance to the Broadly Neutralizing Human Monoclonal Antibody, VRC01.
    Tachibana S; Sasaki M; Tanaka T; Inoue M; Ophinni Y; Kotaki T; Kameoka M
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1248-1257. PubMed ID: 28903577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells.
    Nasreddine N; Borde C; Gozlan J; Bélec L; Maréchal V; Hocini H
    J Immunol; 2011 May; 186(10):5687-95. PubMed ID: 21478402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
    Cunningham CK; McFarland EJ; Morrison RL; Capparelli EV; Safrit JT; Mofenson LM; Mathieson B; Valentine ME; Perlowski C; Smith B; Hazra R; Purdue L; Muresan P; Harding PA; Mbengeranwa T; Robinson LG; Wiznia A; Theron G; Lin B; Bailer RT; Mascola JR; Graham BS;
    J Infect Dis; 2020 Jul; 222(4):628-636. PubMed ID: 31681963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.
    Tudor D; Yu H; Maupetit J; Drillet AS; Bouceba T; Schwartz-Cornil I; Lopalco L; Tuffery P; Bomsel M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12680-5. PubMed ID: 22723360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells.
    Pritschet K; Donhauser N; Schuster P; Ries M; Haupt S; Kittan NA; Korn K; Pöhlmann S; Holland G; Bannert N; Bogner E; Schmidt B
    Virology; 2012 Feb; 423(2):152-64. PubMed ID: 22209232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention.
    Kwon YD; Asokan M; Gorman J; Zhang B; Liu Q; Louder MK; Lin BC; McKee K; Pegu A; Verardi R; Yang ES; Program VP; Carlton K; Doria-Rose NA; Lusso P; Mascola JR; Kwong PD
    MAbs; 2021; 13(1):1946918. PubMed ID: 34328065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
    Corey L; Gilbert PB; Juraska M; Montefiori DC; Morris L; Karuna ST; Edupuganti S; Mgodi NM; deCamp AC; Rudnicki E; Huang Y; Gonzales P; Cabello R; Orrell C; Lama JR; Laher F; Lazarus EM; Sanchez J; Frank I; Hinojosa J; Sobieszczyk ME; Marshall KE; Mukwekwerere PG; Makhema J; Baden LR; Mullins JI; Williamson C; Hural J; McElrath MJ; Bentley C; Takuva S; Gomez Lorenzo MM; Burns DN; Espy N; Randhawa AK; Kochar N; Piwowar-Manning E; Donnell DJ; Sista N; Andrew P; Kublin JG; Gray G; Ledgerwood JE; Mascola JR; Cohen MS;
    N Engl J Med; 2021 Mar; 384(11):1003-1014. PubMed ID: 33730454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes.
    Peressin M; Proust A; Schmidt S; Su B; Lambotin M; Biedma ME; Laumond G; Decoville T; Holl V; Moog C
    AIDS; 2014 Mar; 28(5):667-77. PubMed ID: 24451159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation.
    Schmidt B; Scott I; Whitmore RG; Foster H; Fujimura S; Schmitz J; Levy JA
    Virology; 2004 Nov; 329(2):280-8. PubMed ID: 15518808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    Mayer KH; Seaton KE; Huang Y; Grunenberg N; Isaacs A; Allen M; Ledgerwood JE; Frank I; Sobieszczyk ME; Baden LR; Rodriguez B; Van Tieu H; Tomaras GD; Deal A; Goodman D; Bailer RT; Ferrari G; Jensen R; Hural J; Graham BS; Mascola JR; Corey L; Montefiori DC; ;
    PLoS Med; 2017 Nov; 14(11):e1002435. PubMed ID: 29136037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.
    Sagar M; Akiyama H; Etemad B; Ramirez N; Freitas I; Gummuluru S
    J Infect Dis; 2012 Apr; 205(8):1248-57. PubMed ID: 22396600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells.
    Su B; Biedma ME; Lederle A; Peressin M; Lambotin M; Proust A; Decoville T; Schmidt S; Laumond G; Moog C
    J Virol; 2014 May; 88(9):5109-21. PubMed ID: 24574390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4-Induced Antibodies Promote Association of the HIV-1 Envelope Glycoprotein with CD4-Binding Site Antibodies.
    Gardner MR; Fellinger CH; Prasad NR; Zhou AS; Kondur HR; Joshi VR; Quinlan BD; Farzan M
    J Virol; 2016 Sep; 90(17):7822-32. PubMed ID: 27334589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.
    Schmidt B; Ashlock BM; Foster H; Fujimura SH; Levy JA
    Virology; 2005 Dec; 343(2):256-66. PubMed ID: 16278001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth.
    Chen X; Zhou T; Schmidt SD; Duan H; Cheng C; Chuang GY; Gu Y; Louder MK; Lin BC; Shen CH; Sheng Z; Zheng MX; Doria-Rose NA; Joyce MG; Shapiro L; Tian M; Alt FW; Kwong PD; Mascola JR
    Immunity; 2021 Feb; 54(2):324-339.e8. PubMed ID: 33453152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.
    Holl V; Peressin M; Schmidt S; Decoville T; Zolla-Pazner S; Aubertin AM; Moog C
    Blood; 2006 Jun; 107(11):4466-74. PubMed ID: 16469871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.
    Wilen CB; Parrish NF; Pfaff JM; Decker JM; Henning EA; Haim H; Petersen JE; Wojcechowskyj JA; Sodroski J; Haynes BF; Montefiori DC; Tilton JC; Shaw GM; Hahn BH; Doms RW
    J Virol; 2011 Sep; 85(17):8514-27. PubMed ID: 21715507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.